PHARMING NOMINATES MR ROBIN WRIGHT AS CHIEF FINANCIAL OFFICER

摘要

Pharming Group NV (EURONEXT: PHARM) today announces the proposed election of Mr Robin Wright as the Company's new Chief Financial Officer (CFO) and member of the Management Board at an Extraordinary General Meeting ("EGM") of shareholders, to be held on Wednesday 28 October 2015 at 14:00 hrs CET. Mr Wright will be responsible for the financial management, accounting and investor relations activities of the Company within the CFO role, which has previously been undertaken by CEO, Dr De Vries, and will serve as a member of the. Board of Management. Fallowing the election of Mr Wright to the Board, the Board of Management will consist of Mr Robin Wright (CFO), Prof Bruno Giannetti (COO) and Dr Sijmen de Vries (CEO and Chairman).